Monoclonal Antibodies
Dupilumab for Eczema
Recruiting3 awardsPhase 3
Birmingham, Alabama
This trial is testing the long-term safety and efficacy of dupilumab, a medication used to treat eczema, in children. The trial will also assess the levels of functional dupilumab in the blood after repeated treatment and the immunogenicity of the medication.
Monoclonal Antibodies
Amlitelimab for Eczema
Recruiting1 awardPhase 2 & 3
Miami, Florida
This trial is testing amlitelimab, a medication for adults with moderate to severe atopic dermatitis who were in a previous trial. The study aims to see if the medication is safe and effective over an extended time. Amlitelimab works by calming the immune system to reduce skin inflammation.
Popular Filters
Trials for Eczema Patients
Behavioural Intervention
Team-Based Connected Health (TCH) for Eczema of the Ear Canal
Recruiting1 award6 criteria
Los Angeles, California
This trial will compare an online team-based model for managing atopic dermatitis to in-person care. It will measure disease severity, quality of life, access to care, and costs.
Phase 3 Trials
Janus Kinase (JAK) Inhibitor
Abrocitinib for Atopic Dermatitis/Eczema
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing a pill called Abrocitinib to help people aged 12 and older with severe eczema. It aims to see if the pill can reduce inflammation and itching by blocking certain body chemicals. The study includes patients who have already participated in a related study.
Monoclonal Antibodies
Lebrikizumab for Eczema
Recruiting2 awardsPhase 3
Anniston, Alabama
This trial is testing the safety and effectiveness of lebrikizumab, a medication for eczema. It targets people with moderate-to-severe atopic dermatitis, including those from previous studies and new participants. Lebrikizumab works by blocking a protein that causes inflammation and itching.
Janus Kinase (JAK) Inhibitor
Upadacitinib for Eczema
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing upadacitinib, an oral medication, to see if it can help people with severe eczema. The medication works by calming down the overactive immune system to reduce skin inflammation and itching. Upadacitinib is approved in many countries for the treatment of atopic dermatitis in individuals whose disease is not adequately controlled with other treatments or when those treatments are not suitable.
Trials With No Placebo
Monoclonal Antibodies
Lebrikizumab for Eczema
Recruiting2 awardsPhase 3
Anniston, Alabama
This trial is testing the safety and effectiveness of lebrikizumab, a medication for eczema. It targets people with moderate-to-severe atopic dermatitis, including those from previous studies and new participants. Lebrikizumab works by blocking a protein that causes inflammation and itching.
Behavioural Intervention
Team-Based Connected Health (TCH) for Eczema of the Ear Canal
Recruiting1 award6 criteria
Los Angeles, California
This trial will compare an online team-based model for managing atopic dermatitis to in-person care. It will measure disease severity, quality of life, access to care, and costs.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.